Bi X - Search Results

1

A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer.

Hua X, Duan F, Huang J, Bi X, Xia W, Song C, Wang L, Jiang C, Yuan Z. Hua X, et al. Among authors: bi x. Front Cell Dev Biol. 2021 Nov 4;9:777215. doi: 10.3389/fcell.2021.777215. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805180 Free PMC article.

2

Primary female genital system lymphoma: a single institution's experience over 10 years.

Wei WX, Huang JJ, Wang Y, Xia Y, Bi XW, Jiang WQ, Huang HQ, Lin TY, Li ZM. Wei WX, et al. Hematol Oncol. 2014 Sep;32(3):162-4. doi: 10.1002/hon.2118. Epub 2014 Jan 8. Hematol Oncol. 2014. PMID: 24399793 No abstract available.

3

Treatment outcome of patients with advanced stage natural killer/T-cell lymphoma: elucidating the effects of asparaginase and postchemotherapeutic radiotherapy.

Bi XW, Jiang WQ, Zhang WW, Huang JJ, Xia Y, Wang Y, Sun P, Li ZM. Bi XW, et al. Ann Hematol. 2015 Jul;94(7):1175-84. doi: 10.1007/s00277-015-2336-9. Epub 2015 Feb 17. Ann Hematol. 2015. PMID: 25687842

4

The extent of local tumor invasion predicts prognosis in stage IE nasal natural killer/T-cell lymphoma: a novel T staging system for risk stratification.

Bi XW, Zhang WW, Li ZM, Huang JJ, Xia Y, Sun P, Wang Y, Jiang WQ. Bi XW, et al. Ann Hematol. 2015 Sep;94(9):1515-24. doi: 10.1007/s00277-015-2390-3. Epub 2015 May 1. Ann Hematol. 2015. PMID: 25924921 Clinical Trial.

5

Radiotherapy and PGEMOX/GELOX regimen improved prognosis in elderly patients with early-stage extranodal NK/T-cell lymphoma.

Bi XW, Xia Y, Zhang WW, Sun P, Liu PP, Wang Y, Huang JJ, Jiang WQ, Li ZM. Bi XW, et al. Ann Hematol. 2015 Sep;94(9):1525-33. doi: 10.1007/s00277-015-2395-y. Epub 2015 May 10. Ann Hematol. 2015. PMID: 25957850 Clinical Trial.

6

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.

Song CG, Huang JJ, Li YJ, Xia Y, Wang Y, Bi XW, Jiang WQ, Huang HQ, Lin TY, Li ZM. Song CG, et al. PLoS One. 2015 Jul 29;10(7):e0133973. doi: 10.1371/journal.pone.0133973. eCollection 2015. PLoS One. 2015. PMID: 26222726 Free PMC article.

7

Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.

Wang Y, Li YJ, Jiang WQ, Rao HL, Huang JJ, Xia Y, Bi X, Sun P, Huang HQ, Lin TY, Guan ZZ, Li ZM. Wang Y, et al. Among authors: bi x. Ann Hematol. 2015 Nov;94(11):1865-73. doi: 10.1007/s00277-015-2490-0. Epub 2015 Sep 2. Ann Hematol. 2015. PMID: 26327569

8

High risk of deep vein thrombosis associated with peripherally inserted central catheters in lymphoma.

Zhang X, Huang JJ, Xia Y, Li CF, Wang Y, Liu PP, Bi XW, Sun P, Lin TY, Jiang WQ, Li ZM. Zhang X, et al. Among authors: bi xw. Oncotarget. 2016 Jun 7;7(23):35404-11. doi: 10.18632/oncotarget.8639. Oncotarget. 2016. PMID: 27078849 Free PMC article.

9

A comparison of R-EPOCH and R-CHOP as a first-line regimen in de novo DLBCL patients with high Ki-67 expression in a single institution.

Huang JJ, Xia Y, Wang Y, Liu PP, Bi XW, Sun P, Lin TY, Jiang WQ, Li ZM. Huang JJ, et al. Oncotarget. 2016 Jul 5;7(27):41242-41250. doi: 10.18632/oncotarget.9271. Oncotarget. 2016. PMID: 27183909 Free PMC article.

10

The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer.

Wang X, Bi X, Huang Z, Huang J, Xia W, Shi W, Yuan Z. Wang X, et al. Among authors: bi x. Endocr Relat Cancer. 2020 Apr;27(4):199-208. doi: 10.1530/ERC-19-0315. Endocr Relat Cancer. 2020. PMID: 31958314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,070 results

Search Page

Filters